GB Patent

GB1115893A — Pharmaceutical anti-allergic compositions

Assigned to MSD International Holdings GmbH · Expires 1968-05-29 · 58y expired

What this patent protects

Pharmaceutical compositions for treating allergies comprise a carrier and, as active ingredient 6a - halo - or 6a - lower alkyl - 6 - lower alkyl derivatives of 1, 4 - pregnadene - 17a , 21 - diol - 3, 20 - diene or 1, 4, 9(11) - pregnatriene - 17a , 21 - diol - 3, 20 - dione o…

USPTO Abstract

Pharmaceutical compositions for treating allergies comprise a carrier and, as active ingredient 6a - halo - or 6a - lower alkyl - 6 - lower alkyl derivatives of 1, 4 - pregnadene - 17a , 21 - diol - 3, 20 - diene or 1, 4, 9(11) - pregnatriene - 17a , 21 - diol - 3, 20 - dione or a 21 - ester thereof. The term "lower" signifies groups containing up to 4 carbon atoms. They may be in conventional forms for oral, parenteral, topical or ophthalmic administration and may also include antihistamines, antibiotics adsenocartical steroids; caffeine, aspirin and acetophenetidine.

Drugs covered by this patent

Patent Metadata

Patent number
GB1115893A
Jurisdiction
GB
Classification
—
Expires
1968-05-29
Drug substance claim
No
Drug product claim
No
Assignee
MSD International Holdings GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.